Federal Register of Legislation - Australian Government

Primary content

PB 30 of 2011 Specifications as made
This Specification amends the National Health Act (Pharmaceutical Benefits - Early Supply) Instrument 2009 - specification under subsection 84AAA(2) (No. PB 30 of 2009) that lists the medicines for which Pharmaceutical Benefits Scheme Safety Net entitlements will not apply when the next supply of the same medicine is obtained within 20 days.
Administered by: Health
Registered 30 Mar 2011
Tabling HistoryDate
Tabled HR10-May-2011
Tabled Senate10-May-2011
Date of repeal 19 Mar 2014
Repealed by Health (Spent and Redundant Instruments) Repeal Regulation 2014

 

COMMONWEALTH OF AUSTRALIA

Instrument number PB 30 of 2011

National Health Act (Pharmaceutical Benefits – Early Supply) Amendment April 2011 - Specification Under Subsection 84AAA(2)

 

Amendment determination under subsection 84AAA(2) of the National Health Act 1953

 

I, Adriana Platona, Assistant Secretary, Pharmaceutical Evaluation Branch, Pharmaceutical Benefits Division, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this Instrument under subsection 84AAA(2) of the National Health Act 1953.

 

Dated         25 March 2011

 

 

ADRIANA PLATONA

Assistant Secretary

Pharmaceutical Evaluation Branch

Pharmaceutical Benefits Division

Department of Health and Ageing

 

 

 

Amendment determination — Pharmaceutical Benefits - Early Supply

 

 

1          Name of Instrument

 

(1)           This Instrument is the National Health Act (Pharmaceutical Benefits – Early Supply) Amendment April 2011 - specification under subsection 84AAA(2).

 

(2)           This Instrument may also be cited as No. PB 30 of 2011.


 

2          Commencement

 

This Instrument commences on 1 April 2011.

 

 

3          Amendment of PB 30 of 2009

 

Schedule 1 amends the National Health (Pharmaceutical Benefits – Early Supply) Instrument 2009, PB 30 of 2009.

 


Schedule 1        Amendments

[1]                       Schedule 1, after item dealing with Dipyridamole with aspirin

insert in the columns in the order indicated:

 

Dutasteride

Capsule 500 micrograms

Oral

30

5

 

[2]                       Schedule 1, item dealing with Amlodipine with valsartan

insert in the columns in the order indicated:

 

Amlodipine with valsartan

Tablet 5 mg (as besylate)-320 mg

Oral

28

5

 

Tablet 10 mg (as besylate)-320 mg

Oral

28

5

 

[3]                       Schedule 1, item dealing with Mesalazine, Sachet containing prolonged release granules, 1 g per sachet

omit from the column headed “Maximum quantity or number of units”:

100

and substitute:

120